Mr. Chair, I am pleased to talk about our response to ensuring that Canadians have access to therapeutics, vaccines and treatments as they arise. I am very proud of the hard-working civil service that is working closely with members of the COVID-19 Vaccine Task Force, the COVID-19 Immunity Task Force and the many other experts who are advising us as a country on how best to position ourselves to ensure that we have access to these therapeutics.
As you will know, Mr. Chair, this is a space that is rapidly evolving and Canada is engaged with international partners to ensure that we are at the cutting edge of understanding new treatments and vaccines as they become available.